Quanterix (QTRX) Trading Update
- Current Price: USD 2.79 per share
- Market Capitalization: USD 131 million
- Shares Outstanding: 47.3 million
- Trading Volume (last 24 h): USD 1.5 million
- 24‑Hour Change: –1.81 %
- Monthly Change (from last month‑end): –10.53 %
Technical Indicators
| Indicator | Value |
|---|---|
| Simple Moving Average (200 days) | USD 4.03 |
| 52‑Week High | USD 8.77 (01 Sep 2026) |
| 52‑Week Low | USD 2.15 (08 Oct 2026) |
Related Stock Performance (Last 24 h)
| Symbol | Company | 24‑Hour Change | Current Price | Market Capitalization |
|---|---|---|---|---|
| INAC | Indigo Acquisition | –0.1 % | USD 10.45 | USD 153.3 million |
| ONEW | Onewater Marine | +0.32 % | USD 9.32 | USD 155.8 million |
| YCY | Aa Mission Acquisition | –0.1 % | USD 10.30 | USD 151.8 million |
| ESP | Espey Mfg & Electronics | –0.24 % | USD 54.18 | USD 155.7 million |
| UPB | Upstream Bio | +0.71 % | USD 2.80 | USD 153.4 million |
Highlights of Recent Announcements
Onewater Marine (ONEW)
- Appointed Mike Nance as head of Florida sales operations.
- Focus on strengthening ties with marine manufacturers and expanding dealer networks.
- Nance will lead the sales team at the forthcoming Fort Lauderdale International Boat Show.
- Company emphasizes development of a unified retail, distribution, and service platform.
Espey Mfg & Electronics (ESP)
- Reported seismic and flow‑testing results indicating potential for commercial natural hydrogen and helium production.
- Expanded survey covers cross‑border region to image key structural features.
- Flow‑testing at three wells confirmed helium extraction feasibility and identified natural hydrogen presence.
- Plans include a modular development strategy and further laboratory and modelling studies.
Upstream Bio (UPB) / Northpointe Bancshares
- Northpointe reported Q3 2026 earnings, noting growth in mortgage purchase and home‑equity loan businesses.
- Earnings decline attributed to fair‑value adjustments and a deposit‑fraud incident, mitigated by enhanced controls.
- Company intends to sell distributed retail and consumer‑direct mortgage origination channels to CMG Financial by year‑end.
- Anticipated restructuring charges for Q4; details to be disclosed during the earnings call on October 21.
Company Overview
Quanterix Corporation
- Industry: Health care technology
- Headquarters: Lexington, United States
- Specialty: Ultra‑sensitive detection systems for research and in‑vitro diagnostics
- Product Focus: Automated immunoassay technology for biomarker detection in in‑vitro and companion diagnostics, including blood screening
- Market Presence: Life sciences, oncology, and neurology research sectors in the United States
- Website: www.quanterix.com
- Exchange: Nasdaq
- IPO Date: December 7, 2017